Vasopressin Infusion Rate Calculator

About This Vasopressin Infusion Rate Calculator

This Vasopressin Infusion Rate Calculator is designed for healthcare professionals to rapidly and accurately determine the infusion rate (mL/hr) for vasopressin based on a desired dose in units per minute. In critical care environments, particularly during the management of septic shock, vasopressin is a key therapeutic agent. Converting a fixed dose to a volumetric pump rate is a frequent and critical calculation. This tool streamlines that process, reducing the risk of manual calculation errors and ensuring patient safety. It can be used for any concentration, whether from a commercially prepared premixed bag or a manually compounded dilution.

The Formula Explained

The calculation is a two-step process that first determines the concentration of the prepared solution and then uses it to find the required infusion rate.

Step 1: Determine Drug Concentration

Step 2: Calculate Infusion Rate

Clinical Interpretation & Limitations

The output provides the specific infusion pump rate (mL/hr) to deliver a standard dose of vasopressin. Its clinical application is well-defined in guidelines for septic shock.

• Indication: Used as a catecholamine-sparing second agent in septic shock. Per the 2026 Surviving Sepsis Campaign (SSC 2026), vasopressin is typically added when norepinephrine requirements are escalating, to support the target Mean Arterial Pressure (MAP) and reduce the norepinephrine dose.
• Dosing Strategy: The Surviving Sepsis Campaign guidelines recommend a fixed infusion rate of 0.03 units/minute. Doses higher than 0.04 units/minute are not typically recommended for septic shock as they may increase the risk of adverse events without providing additional benefit.
• Mechanism: Vasopressin is a non-adrenergic vasopressor that acts on V1 receptors on vascular smooth muscle, causing vasoconstriction and increasing systemic vascular resistance. This mechanism is complementary to alpha-adrenergic agonists like norepinephrine.

Limitations

This calculator is a tool to aid, not replace, clinical judgment. All calculations for high-risk medications should be independently verified. This tool does not account for IV line dead space or drug stability over time. Always adhere to your institution’s specific protocols for vasopressor administration.

Frequently Asked Questions (FAQ)

1. Why is vasopressin not titrated based on blood pressure?

Unlike norepinephrine, vasopressin is used for its catecholamine-sparing effects at a low, fixed dose. Studies have not shown a benefit to titrating the dose for blood pressure response in septic shock, and higher doses are associated with increased risks of ischemia.

2. Can vasopressin be administered through a peripheral IV line?

Vasopressin is conventionally given through a central venous catheter because it is a potent vasoconstrictor and vesicant. The 2026 Surviving Sepsis Campaign (SSC 2026) makes a general, vasopressor-class conditional suggestion to start vasopressors peripherally rather than delay treatment to obtain central access; this recommendation rests on very low certainty evidence and does not specifically endorse peripheral vasopressin. Where vasopressin is given peripherally, monitor closely for extravasation (leakage into surrounding tissue), which can cause severe tissue ischemia and necrosis, and transition to central access as soon as feasible.

3. What are the most common concentrations for vasopressin infusions?

Common concentrations prepared by pharmacies include 20 units in 100 mL (0.2 units/mL) and 40 units in 100 mL (0.4 units/mL). For manual dilution, a common practice is to add 100 units to 500 mL of diluent, resulting in a 0.2 units/mL concentration.

4. How does vasopressin differ from Norepinephrine?

Norepinephrine is a catecholamine that primarily acts on alpha-1 adrenergic receptors. Vasopressin is an endogenous hormone (ADH) that acts on V1 receptors. They have different mechanisms and are used together synergistically. Norepinephrine is the first-line, titratable agent, while vasopressin is a second-line, fixed-dose agent.

5. What adverse effects should be monitored during vasopressin infusion?

Clinicians should monitor for signs of excessive vasoconstriction, which can lead to cardiac, digital (fingers/toes), or splanchnic (gut) ischemia. Due to its antidiuretic effects, it can also cause water retention and hyponatremia, so serum sodium should be monitored.